Rothschild Investment LLC’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.23K Sell
371
-57
-13% -$1.33K ﹤0.01% 1931
2026
Q1
$6K Buy
428
+272
+174% +$3.67K ﹤0.01% 1963
2025
Q4
$1.75K Sell
156
-85
-35% -$973 ﹤0.01% 2443
2025
Q3
$2.79K Buy
241
+25
+12% +$293 ﹤0.01% 2016
2025
Q2
$2.64K Buy
216
+100
+86% +$1.26K ﹤0.01% 1871
2025
Q1
$1.66K Buy
116
+65
+127% +$1.01K ﹤0.01% 2013
2024
Q4
$812 Sell
51
-32
-39% -$633 ﹤0.01% 2345
2024
Q3
$1.99K Buy
83
+19
+30% +$434 ﹤0.01% 1728
2024
Q2
$1.27K Buy
64
+5
+8% +$97 ﹤0.01% 1545
2024
Q1
$1.18K Buy
59
+5
+9% +$97 ﹤0.01% 1251
2023
Q4
$1.21K Buy
+54
New +$1.11K ﹤0.01% 1184

Other funds holding AVNS

Rothschild Investment LLC's AVNS Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Avanos Medical (AVNS) stake by 13% in Q2 2026, selling an estimated $1.33K and leaving 371 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Rothschild Investment LLC first reported a position in AVNS in Q4 2023 and has held it in 11 quarters since. 116 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Rothschild Investment LLC held 371 shares of Avanos Medical worth $9.23K as of Q2 2026.
  • Rothschild Investment LLC sold 57 Avanos Medical shares in Q2 2026, an estimated $1.33K.
  • Avanos Medical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1931 holding.
  • Rothschild Investment LLC first reported a position in Avanos Medical in Q4 2023 and has held it in 11 quarters since.
  • 116 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.